Docetaxel followed by hormone therapy after failure of definitive treatments for clinically localized/locally advanced prostate cancer: Preliminary results
Authors:
- Nancy DawsonNDNancy Dawson
- Pradip AminPAPradip Amin
- Michael NaslundMNMichael Naslund
- Christine EngstromCEChristine Engstrom
- Timothy ChenTCTimothy Chen
- 1 August 2001
- journal article
- clinical trial
- Published by Elsevier in Seminars in Oncology
- Vol. 28, 22-31
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Phase II Study of Docetaxel, Estramustine, and Low-Dose Hydrocortisone in Men With Hormone-Refractory Prostate Cancer: A Final Report of CALGB 9780Journal of Clinical Oncology, 2001
- Natural History of Progression After PSA Elevation Following Radical ProstatectomyJAMA, 1999
- Ca 2+ -Induced Apoptosis Through Calcineurin Dephosphorylation of BADScience, 1999
- Expression of BCL-2 Oncoprotein and P53 Protein Accumulation in Bone Marrow Metastases of Androgen Independent Prostate CancerJournal of Urology, 1997
- The Use of Radiotherapy for Patients with Isolated Elevation of Serum Prostate Specific Antigen Following Radical ProstatectomyJournal of Urology, 1996
- Radioimmunoscintigraphy with111Indium Labeled Cyt-356 for the Detection of Occult Prostate Cancer RecurrenceJournal of Urology, 1994
- Radical prostatectomy for adenocarcinoma of the prostate: The influence of preoperative and pathologic findings on biochemical disease-free outcomeUrology, 1994
- Is Prostate Specific Antigen of Clinical Importance in Evaluating Outcome after Radical ProstatectomyJournal of Urology, 1993
- Role of calcium in the programmed death of rat prostatic glandular cellsThe Prostate, 1990